SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-301017
Filing Date
2021-10-18
Accepted
2021-10-18 16:02:03
Documents
12
Period of Report
2021-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d208158d8k.htm   iXBRL 8-K 24814
  Complete submission text file 0001193125-21-301017.txt   146873

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20211016.xsd EX-101.SCH 2905
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20211016_lab.xml EX-101.LAB 18140
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20211016_pre.xml EX-101.PRE 11417
5 EXTRACTED XBRL INSTANCE DOCUMENT d208158d8k_htm.xml XML 3382
Mailing Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362
Business Address 30930 RUSSELL RANCH ROAD SUITE 300 WESTLAKE VILLAGE CA 91362 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 211328317
SIC: 2834 Pharmaceutical Preparations